May 17, 2025, 1:15 a.m.
Biotech's DeepSeek moment: Hong Kong investor ORI sees opportunity in China with new fund
ORI Capital is planning a US$350 million fund to focus on Chinese biotech, with hopes that AI will help beat the market.
Biotech's DeepSeek moment: Hong Kong investor ORI sees opportunity in China with new fund
ORI Capital is planning a US$350 million fund to focus on Chinese biotech, with hopes that AI will help beat the market.